feed info

15 articles from Yahoo!

Remdesivir questioned by WHO trial; women take virus more seriously than men

In a blow to one of the few drugs being used to treat COVID-19, the World Health Organization (WHO) said interim trial results suggest that Gilead's remdesivir was no better than a placebo at limiting severely ill patients' need for mechanical ventilation, the length of their hospital stay, or their risk of death. Then, the authors looked at data on nearly 740,000 COVID-19 patients and examined...

Touch-and-go: US spacecraft sampling asteroid for return

After almost two years circling an ancient asteroid hundreds of millions of miles away, a NASA spacecraft this week will attempt to descend to the treacherous, boulder-packed surface and snatch a handful of rubble. The drama unfolds Tuesday as the U.S. takes its first crack at collecting asteroid samples for return to Earth, a feat accomplished so far only by Japan. Brimming with names inspired...

WHO study finds remdesivir didn't help COVID-19 patients

A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a standard of care in the United States and many other countries. The results announced Friday do not negate the previous ones, and the WHO study was not as rigorous as the earlier one led by the U.S....

World caught in 'syndemic' of chronic diseases and COVID-19, global study says

The world is caught in a perfect storm of rising rates of chronic disease, persistent infectious diseases and public health failures that have fuelled deaths in the COVID-19 pandemic, according to a major global study of human health. The emergence and overlap of the coronavirus pandemic with a continued global rise in chronic conditions such as obesity and diabetes - with added environmental...

WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients

The antiviral medication, among the first to be used as a treatment for COVID-19, was one of the drugs recently used to treat U.S. President Donald Trump's coronavirus infection. The results are from WHO's "Solidarity" trial, which evaluated the effects of four potential drug regimens, including remdesivir, hydroxychloroquine, anti-HIV drug combination lopinavir/ritonavir and interferon, in...

World caught in "syndemic" of chronic diseases and COVID-19, global study says

The world is caught in a perfect storm of rising rates of chronic disease, persistent infectious diseases and public health failures that have fuelled deaths in the COVID-19 pandemic, according to a major global study of human health. The emergence and overlap of the coronavirus pandemic with a continued global rise in chronic conditions such as obesity and diabetes - with added environmental...

WHO study says remdesivir did not cut hospital stay or mortality in COVID-19 patients - FT

The antiviral drug, among the first to be used as a treatment for COVID-19, was one of the drugs recently used to treat U.S. President Donald Trump's coronavirus infection. The FT report cites results from WHO's Solidarity trial that evaluated effects of four potential drug regimens, including remdesivir, hydroxychloroquine, anti-HIV combination drug of lopinavir/ritonavir, and interferon, in...